Keywords: مستقیم مهار کننده ترومبین; Cerebrovascular complication; DOAC; direct thrombin inhibitor; factor Xa inhibitor; efficacy and safety; PMDA;
مقالات ISI مستقیم مهار کننده ترومبین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مستقیم مهار کننده ترومبین; DDD; defined daily dose; DTI; direct thrombin inhibitor; ELISA; enzyme-linked immunosorbent assay; HIT; heparin induced thrombocytopenia; HITT; heparin induced thrombocytopenia with thrombosis; SRA; serotonin release assay; T≻ test and switch, continue
Keywords: مستقیم مهار کننده ترومبین; anticoagulant; atrial arrhythmia; direct thrombin inhibitor; heart failure; remodelingAF, atrial fibrillation; ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide; CTGF, connective tissue growth factor; DTI, direct thrombin inhibitor; MHC, myo
Keywords: مستقیم مهار کننده ترومبین; direct thrombin inhibitor; factor Xa inhibitor; hemorrhage; mortality; warfarin; AF; atrial fibrillation; AMI; acute myocardial infarction; ASMD; absolute standardized mean difference; CI; confidence interval; CKD; chronic kidney disease; GI; gastrointest
Keywords: مستقیم مهار کننده ترومبین; Dabi; dabigatran; DTI; direct thrombin inhibitor; PT; prothrombin time; APTT; activated partial thromboplastin time; TT; thrombin time; ECA; ecarin clotting assay; HTI; Hemoclot Thrombin Inhibitors; LC-MS/MS; liquid chromatography-tandem mass spectrometry
Keywords: مستقیم مهار کننده ترومبین; Anticoagulants/Administration and Dosage; Atrial Fibrillation; Drug Administration Schedule; Drug Monitoring; Thrombosis/Drug Therapy; Endoscopy; Gastrointestinal; AF; atrial fibrillation; aPTT; activated partial thromboplastin time; CrCl; creatinine clea
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: مستقیم مهار کننده ترومبین; AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration
Keywords: مستقیم مهار کننده ترومبین; APTT; activated partial thromboplastin time; APTT-Cepha; APTT using Cephascreen® (Diagnostica Stago) reagent; APTT-PSL; APTT using Pathromtin®SL (Siemens Healthcare) reagent; ANOVA; analysis of variance; CAT; calibrated automated thrombinography; CT; cl
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke
Keywords: مستقیم مهار کننده ترومبین; Stroke volume; recurrent; NOAC; DOAC; direct thrombin inhibitor; dabigatran; factor Xa inhibitor; rivaroxaban; apixaban; edoxaban; warfarin;
Implementation of a rapid HIT immunoassay at a university hospital - Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia
Keywords: مستقیم مهار کننده ترومبین; CLIA; chemiluminescent immunoassay; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thrombocytopenia; ICU; intensive care unit
Full Length ArticleDirect thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice
Keywords: مستقیم مهار کننده ترومبین; Cardiac fibrosis; Direct thrombin inhibitor; Protease-activated receptor; Thrombin;
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study
Keywords: مستقیم مهار کننده ترومبین; DOAC measurement; PT; aPTT; Direct factor Xa inhibitor; Direct thrombin inhibitor; Anti-Xa activity; Ecarin assay; Dilute thrombin time;
Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician
Keywords: مستقیم مهار کننده ترومبین; novel oral anticoagulants; dabigatran; rivaroxaban; edoxaban; apixaban; direct thrombin inhibitor; factor Xa; atrial fibrillation; activated charcoal; prothrombin complex concentrates; vitamin K antagonists; warfarin; recombinant factor VIIa; idarucizumab
Original InvestigationAcute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin
Keywords: مستقیم مهار کننده ترومبین; acute kidney injury; atrial fibrillation; direct thrombin inhibitor; warfarin; AF; atrial fibrillation; AKI; acute kidney injury; ASMD; absolute standardized mean difference; CHA2DS2-VASc; congestive heart failure, hypertension, age 75 years or older, dia
Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin
Keywords: مستقیم مهار کننده ترومبین; Intrinsic pathway; Direct thrombin inhibitor; Melagatran; Activated protein C; Direct factor Xa inhibitor; Edoxaban
Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis
Keywords: مستقیم مهار کننده ترومبین; aPTT; activated partial thromboplastin time; CI; confidence interval; CV; coefficient of variation; DTI; direct thrombin inhibitor; dTT; diluted thrombin time; ECT; ecarin clotting time; EDTA; ethylenediaminetetraacetic acid; ESRD; end-stage renal disease
Impact of dabigatran on platelet function and fibrinolysis
Keywords: مستقیم مهار کننده ترومبین; Dabigatran; Direct thrombin inhibitor; Platelet function; Fibrinolysis; Ischemic stroke; Atrial fibrillation;
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
Keywords: مستقیم مهار کننده ترومبین; DOAC; Direct thrombin inhibitor; Direct Xa inhibitor; Oral anticoagulant; Laboratory assays;
Ordonnance contenant un inhibiteur direct de la thrombine, chez un patient en fibrillation atriale permanente
Keywords: مستقیم مهار کننده ترومبین; Amiodarone; Anticoagulant; Bisoprolol; Dabigatran; Fibrillation atriale permanente; Inhibiteur direct de la trombineAmiodarone; Anticoagulant; Bisoprolol; Dabigatran; Direct thrombin inhibitor; Permanent atrial fibrillation
Hemorrhagic Gastritis with Dabigatran in a Patient with Renal Insufficiency
Keywords: مستقیم مهار کننده ترومبین; dabigatran etexilate; bleeding; reversal; direct thrombin inhibitor; renal insufficiency
Clinical Challenges in a Patient With Dabigatran-Induced Fatal Hemorrhage
Keywords: مستقیم مهار کننده ترومبین; bleeding; dabigatran; direct thrombin inhibitor; prothrombin complex concentrate; recombinant factor VIIa;
Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
Keywords: مستقیم مهار کننده ترومبین; Coagulation assays; Dabigatran; Dabigatran etexilate; Direct thrombin inhibitor
The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2011
Keywords: مستقیم مهار کننده ترومبین; factor Xa inhibitor; rivaroxaban; apixaban; direct thrombin inhibitor; dabigatran; blood conservation guidelines; aminocaproic acid; tranexamic acid; antifibrinolytics; erythropoietin; clopidogrel; platelet blockade; point-of-care testing; fresh frozen pl
Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
Keywords: مستقیم مهار کننده ترومبین; NVAF; Non-valvular atrial fibrillation; VKA; Vitamin K antagonist; INR; International normalized ratio; DTI; Direct thrombin inhibitor; TTA; Total thrombus area; IR; Immediate-release; PK; Pharmacokinetic(s); PD; Pharmacodynamic(s); APTT; Activated partia
Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions
Keywords: مستقیم مهار کننده ترومبین; aPTT; activated partial thromboplastin time; DIC; disseminated intravascular coagulation; DTI; direct thrombin inhibitor; FFP; fresh frozen plasma; INR; international normalized ratio; LMWH; low molecular weight heparin; LP; lumbar puncture; NSAID; nonste
Alcance de los últimos subestudios del RE-LY: implicaciones clÃnicasScope of the latest RE-LY substudies: clinical implications
Keywords: مستقیم مهار کننده ترومبین; Dabigatrán; Estudio RE-LY; Fibrilación auricular no valvular; Inhibidor directo de la trombina; Subanálisis; Subestudios; Dabigatran; RE-LY study; Nonvalvular atrial fibrillation; Direct thrombin inhibitor; Subanalysis; Substudies;
Heparin-Induced Thrombocytopenia
Keywords: مستقیم مهار کننده ترومبین; Heparin-induced thrombocytopenia; Thrombosis; Platelets; PF-4; Direct thrombin inhibitor;
Update in Hematology: Heparin-Induced Thrombocytopenia and Bivalirudin
Keywords: مستقیم مهار کننده ترومبین; heparin; thrombocytopenia; heparin-induced thrombocytopenia; thrombosis; direct thrombin inhibitor; low–molecular-weight heparin; lepirudin; bivalirudin; warfarin; platelet blockade; antibodies; cardiac surgery; percutaneous coronary intervention
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Keywords: مستقیم مهار کننده ترومبین; Direct thrombin inhibitor; Dabigatran; Safety; Efficacy
Conformationally restricted analogs of the direct thrombin inhibitor FM 19
Keywords: مستقیم مهار کننده ترومبین; DTI; direct thrombin inhibitor; HOBt; hydroxybenzotriazole; HBTU; O-benzotriazole-N,N,Nâ²,Nâ²-tetramethyl-uroniumhexafluorophosphate; DIEA; N,N-diisopropylethylamine; Oic; (2S,3aS,7aS)-octahydroindole-2-carboxylic acid; Phe(p-Me); p-methyl phenylalanine
Dabigatran Etexilate Prevents Venous Thromboembolism After Total Knee Arthroplasty in Japanese Patients With a Safety Profile Comparable to Placebo
Keywords: مستقیم مهار کننده ترومبین; dabigatran etexilate; direct thrombin inhibitor; total knee arthroplasty; venous thromboembolism
Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
Keywords: مستقیم مهار کننده ترومبین; Dabigatran etexilate; direct thrombin inhibitor; total knee arthroplasty; prophylaxis; venous thromboembolism
Novel method of expression and purification of hirudin based on pBAD TOPO, pTYB12 vectors and gene synthesis
Keywords: مستقیم مهار کننده ترومبین; Hirudin; pBAD; pTYB12; Direct thrombin inhibitor
The Management of Patients With Heparin-Induced Thrombocytopenia Who Require Anticoagulant Therapy
Keywords: مستقیم مهار کننده ترومبین; anticoagulation; direct thrombin inhibitor; factor Xa inhibitor; heparin-induced thrombocytopenia; heparin reexposure; thromboprophylaxis; CPB; cardiopulmonary bypass; DVT; deep venous thrombosis; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-ind
Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia
Keywords: مستقیم مهار کننده ترومبین; coumarin derivative; direct thrombin inhibitors; heparin-induced thrombocytopenia; indanedione derivative; oral anticoagulants; venous limb gangrene; warfarin-induced skin necrosis; DTI; direct thrombin inhibitor; HIT; heparin-induced thrombocytopenia; IN
Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination
Keywords: مستقیم مهار کننده ترومبین; aPTT; activated partial-thromboplastin time; AT; antithrombin; CT0; clotting time without melagatran; CTm; concentrations of melagatran; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetra-acetic acid; ETP; endogenous thrombin potential; F; coagula
A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays
Keywords: مستقیم مهار کننده ترومبین; ACT; activated clotting time; APTT; activated partial thromboplastin time; DTI; direct thrombin inhibitor; ECT; ecarin clotting time; FV; factor V; IC50; plasma concentration of anticoagulant agent that doubles the clotting time compared with anticoagulan